198 related articles for article (PubMed ID: 35712073)
21. Imiquimod Exerts Antitumor Effects by Inducing Immunogenic Cell Death and Is Enhanced by the Glycolytic Inhibitor 2-Deoxyglucose.
Huang SW; Wang ST; Chang SH; Chuang KC; Wang HY; Kao JK; Liang SM; Wu CY; Kao SH; Chen YJ; Shieh JJ
J Invest Dermatol; 2020 Sep; 140(9):1771-1783.e6. PubMed ID: 32035924
[TBL] [Abstract][Full Text] [Related]
22. Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
Wang C; Zhang M; Peng J; Zhang M; Lu C; Qi X; Luo Q; Wang Y; Li G
Phytomedicine; 2024 Jun; 128():155504. PubMed ID: 38452404
[TBL] [Abstract][Full Text] [Related]
23. Immunogenic Cell Death Inducing Fluorinated Mitochondria-Disrupting Helical Polypeptide Synergizes with PD-L1 Immune Checkpoint Blockade.
Jeong SD; Jung BK; Ahn HM; Lee D; Ha J; Noh I; Yun CO; Kim YC
Adv Sci (Weinh); 2021 Apr; 8(7):2001308. PubMed ID: 33854870
[TBL] [Abstract][Full Text] [Related]
24. Multifunctional carbon monoxide nanogenerator as immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect.
Xiao X; Liang S; Zhao Y; Pang M; Ma P; Cheng Z; Lin J
Biomaterials; 2021 Oct; 277():121120. PubMed ID: 34508956
[TBL] [Abstract][Full Text] [Related]
25. PKHB1, a thrombospondin-1 peptide mimic, induces anti-tumor effect through immunogenic cell death induction in breast cancer cells.
Calvillo-Rodríguez KM; Mendoza-Reveles R; Gómez-Morales L; Uscanga-Palomeque AC; Karoyan P; Martínez-Torres AC; Rodríguez-Padilla C
Oncoimmunology; 2022; 11(1):2054305. PubMed ID: 35402082
[TBL] [Abstract][Full Text] [Related]
26. Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.
Guo ZS; Liu Z; Bartlett DL
Front Oncol; 2014; 4():74. PubMed ID: 24782985
[TBL] [Abstract][Full Text] [Related]
27. Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death.
Hu Q; Wang S; Cheng R; Liu Y; Chang Z; Huang Y; Chen Y; Luo X; Zhou L; Wang B; Gao Y; Chen H; Liu R; Zhang L
Phytomedicine; 2024 Jan; 123():155219. PubMed ID: 38056150
[TBL] [Abstract][Full Text] [Related]
28. The anticancer peptide RT53 induces immunogenic cell death.
Pasquereau-Kotula E; Habault J; Kroemer G; Poyet JL
PLoS One; 2018; 13(8):e0201220. PubMed ID: 30080874
[TBL] [Abstract][Full Text] [Related]
29. Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.
Cruickshank B; Giacomantonio M; Marcato P; McFarland S; Pol J; Gujar S
Front Immunol; 2018; 9():654. PubMed ID: 29666625
[TBL] [Abstract][Full Text] [Related]
30. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
[TBL] [Abstract][Full Text] [Related]
31. Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity.
Wang T; Peng W; Du M; Chen Z
Front Oncol; 2023; 13():1167105. PubMed ID: 37168380
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of immunogenic cell death-related signature for predicting the prognosis and immune landscape of uveal melanoma.
Hu Y; Cai J; Ye M; Mou Q; Zhao B; Sun Q; Lou X; Zhang H; Zhao Y
Front Immunol; 2022; 13():1037128. PubMed ID: 36466923
[TBL] [Abstract][Full Text] [Related]
33. Raddeanin A Enhances Mitochondrial DNA-cGAS/STING Axis-Mediated Antitumor Immunity by Targeting Transactive Responsive DNA-Binding Protein 43.
Yin M; Dong J; Sun C; Liu X; Liu Z; Liu L; Kuang Z; Zhang N; Xiao D; Zhou X; Deng H
Adv Sci (Weinh); 2023 May; 10(13):e2206737. PubMed ID: 36876644
[TBL] [Abstract][Full Text] [Related]
34. Combining PD-L1 blockade with immunogenic cell death induced by AIE photosensitizer to improve antitumor immunity.
Li J; Dai J; Zhuang Z; Meng Z; Hu JJ; Lou X; Xia F; Zhao Z; Tang BZ
Biomaterials; 2022 Dec; 291():121899. PubMed ID: 36343606
[TBL] [Abstract][Full Text] [Related]
35. Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity.
Li J; Han X; Sun M; Li W; Yang G; Chen H; Guo B; Li J; Li X; Wang H
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056894
[TBL] [Abstract][Full Text] [Related]
36. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
Inoue H; Tani K
Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
[TBL] [Abstract][Full Text] [Related]
37. A combination strategy based on an Au nanorod/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle.
Feng ZH; Li ZT; Zhang S; Wang JR; Li ZY; Xu MQ; Li H; Zhang SQ; Wang GX; Liao A; Zhang X
Acta Biomater; 2021 Dec; 136():495-507. PubMed ID: 34619371
[TBL] [Abstract][Full Text] [Related]
38. Development and verification of a novel immunogenic cell death-related signature for predicting the prognosis and immune infiltration in triple-negative breast cancer.
Li J; Li Z; Yang W; Pan J; You H; Yang L; Zhang X
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2007. PubMed ID: 38425247
[TBL] [Abstract][Full Text] [Related]
39. Immunogenic effects of chemotherapy-induced tumor cell death.
Wang YJ; Fletcher R; Yu J; Zhang L
Genes Dis; 2018 Sep; 5(3):194-203. PubMed ID: 30320184
[TBL] [Abstract][Full Text] [Related]
40. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis.
Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D
Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]